Gioacchino Angarano

Gioacchino Angarano publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gioacchino Angarano sits on this spectrum.

Gioacchino Angarano D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gioacchino Angarano sits on this spectrum.

Best Publications

• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

  A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  785
  Citations

• Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

  Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  667
  Citations

• Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

  Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  568
  Citations

• Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men.

  Saracco A;Musicco M;Nicolosi A;Angarano G

  366
  Citations

• Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.

  M. L. Calabrò;J. Sheldon;A. Favero;G. R. Simpson

  201
  Citations

• Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

  Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  174
  Citations

• Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

  P Maggi;Am Larocca;Michele Quarto;Gabriella Serio

  174
  Citations

• Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.

  Massimo Galli;Fabrizio Veglia;Gioacchino Angarano;Sara Santambrogio

  160
  Citations

• Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

  Matteo Bassetti;Nadia Castaldo;Annamaria Cattelan;Cristina Mussini

  156
  Citations

• Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies

  Unknown

  146
  Citations

• The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

  David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  141
  Citations

• Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

  M Milella;G Antonelli;T Santantonio;M Currenti

  133
  Citations

• Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

  Barbara Ensoli;Stefania Bellino;Antonella Tripiciano;Olimpia Longo

  123
  Citations

• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

  Carlo F. Perno;Alessandro Cozzi-Lepri;Claudia Balotta;Federica Forbici

  120
  Citations

• Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV

  I L Simone;F Federico;C Tortorella;C F Andreula

  120
  Citations

• Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

  Antinori A;Marcotullio S;Ammassari A;Andreoni M

  118
  Citations

• Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV-1) Isolates in Two Groups of HIV-1-Infected Long-Term Nonprogressors

  Yi-jun Zhang;Claudio Fracasso;José Ramon Fiore;Åsa Björndal

  111
  Citations

• Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus Load

  Cynthia M. Lyles;Maria Dorrucci;David Vlahov;Patrizio Pezzotti

  101
  Citations

• Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.

  Francesco Mazzotta;Sergio Lo Caputo;Carlo Torti;Carmine Tinelli

  88
  Citations

• The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.

  Rezza G;Lazzarin A;Angarano G;Sinicco A

  87
  Citations